Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Masimo

< Previous 1 2 3 4 Next >
Masimo Named One of Fast Company’s Most Innovative Companies in North America
From Masimo
Via Business Wire
Tickers MASI
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
From Masimo
Via Business Wire
Tickers MASI
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
From Masimo
Via Business Wire
Tickers MASI
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces Reinstatement of Import Ban on Infringing Apple Watches
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces New Member of the Board of Directors
From Masimo
Via Business Wire
Tickers MASI
Masimo Receives FDA Clearance for Stork™ Baby Monitoring System
From Masimo
Via Business Wire
Tickers MASI
New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
From Masimo
Via Business Wire
Tickers MASI
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in Jefferies London Healthcare Conference
From Masimo
Via Business Wire
Tickers MASI
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
From Masimo
Via Business Wire
Tickers MASI
Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7
From Masimo
Via Business Wire
Tickers MASI
Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
From Masimo
Via Business Wire
Tickers MASI
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in Wells Fargo Healthcare Conference
From Masimo
Via Business Wire
Tickers MASI
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
From Masimo
Via Business Wire
Tickers MASI
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
From Masimo
Via Business Wire
Tickers MASI
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
From Masimo
Via Business Wire
Tickers MASI
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients
From Masimo
Via Business Wire
Tickers MASI
Masimo and Clinton Foundation Host Roundtable Addressing Overdose and Addiction Crisis
From Masimo
Via Business Wire
Tickers MASI
Masimo Expands Into the Personalized Hearables Market with Denon PerL™ True Wireless Earbuds, Featuring Masimo Adaptive Acoustic Technology™ (AAT™)
From Masimo
Via Business Wire
Tickers MASI
Community Health System Expands Use of Multiple Masimo Technologies, System-wide
From Masimo
Via Business Wire
Tickers MASI
Masimo to Present in Jefferies Healthcare Conference
From Masimo
Via Business Wire
Tickers MASI
Masimo Announces FDA 510(k) Clearance of Radius VSM™
From Masimo
Via Business Wire
Tickers MASI
Lausanne University Hospital (CHUV) Anesthesiology Department Adopts Masimo W1™ for Use in Preoperative Patient Assessment
From Masimo
Via Business Wire
Tickers MASI
Masimo Board of Directors Sets the Record Straight on False and Misleading Claims
From Masimo
Via Business Wire
Tickers MASI
Masimo Files Investor Presentation Highlighting Track Record of Success, Compelling Strategy, Responsive Governance Changes and Risks Posed by Quentin Koffey’s Agenda
From Masimo
Via Business Wire
Tickers MASI
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.